The Oncosearch | Oncotarget

Characterization of cancer-associated IDH2 mutations that differ in tumorigenicity, chemosensitivity and 2-hydroxyglutarate production Research Paper

Kevin P. Kotredes, Roshanak Razmpour, Evan Lutton, Mercedes Alfonso-Prieto, Servio H. Ramirez, Ana M. Gamero

Published Apr 12, 2019 · Vol. 10, No. 28 · pp. 2675-2692

Keywords: glioblastoma, IDH2, tumorigenesis, chemotherapy, biomarker

Evaluation of gilteritinib in combination with chemotherapy in preclinical models of FLT3-ITD⁺ acute myeloid leukemia Research Paper

Yoko Ueno, Masamichi Mori, Yoshiteru Kamiyama, Rika Saito, Naoki Kaneko, Eriko Isshiki, Sadao Kuromitsu, Masahiro Takeuchi

Published Apr 2, 2019 · Vol. 10, No. 26 · pp. 2530-2545

The combined efficacy of OTS964 and temozolomide for reducing the size of power-law coded heterogeneous glioma stem cell populations Research Paper

Michiya Sugimori, Yumiko Hayakawa, Ryoi Tamura, Satoshi Kuroda

Published Mar 22, 2019 · Vol. 10, No. 24 · pp. 2397-2415

AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple negative breast cancer Research Paper

Marie-Anne Goyette, Rebecca Cusseddu, Islam Elkholi, Afnan Abu-Thuraia, Nehme El-Hachem, Benjamin Haibe-Kains, Jean-Philippe Gratton, Jean-François Côté

Published Mar 12, 2019 · Vol. 10, No. 21 · pp. 2055-2067

Keywords: triple-negative breast cancer, drug repurposing, AXL, phenothiazines, metastasis

ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation Priority Research Paper

Aaditya Khatri, Jing Jin Gu, Courtney M. McKernan, Xia Xu, Ann Marie Pendergast

Published Mar 8, 2019 · Vol. 10, No. 20 · pp. 1874-1886

Phospho-ERK levels as predictors for chemotherapy of rectal carcinoma Research Paper

Susanne Holck, Louise Laurberg Klarskov, Lars-Inge Larsson

Published Mar 1, 2019 · Vol. 10, No. 18 · pp. 1745-1755

Body surface area-based versus concentration-based intraperitoneal perioperative chemotherapy in a rat model of colorectal peritoneal surface malignancy: pharmacologic guidance towards standardization Research Paper

Lieselotte Lemoine, Elsy Thijssen, Robert Carleer, Jirka Cops, Veerle Lemmens, Peter Van Eyken, Paul Sugarbaker, Kurt Van der Speeten

Published Feb 15, 2019 · Vol. 10, No. 14 · pp. 1407-1424

Myeloid cell leukemia-1 dependence in acute myeloid leukemia: a novel approach to patient therapy Review

Tapan Mahendra Kadia, Hagop M. Kantarjian, Marina Konopleva

Published Feb 8, 2019 · Vol. 10, No. 12 · pp. 1250-1265

Taxane & cyclophosphamide vs anthracycline & taxane-based chemotherapy as adjuvant treatment for breast cancer: a pooled analysis of randomized controlled trials by the Hellenic Academy of Oncology Research Paper

Panagiotis Ntellas, Nikolaos Spathas, Sofia Agelaki, Elias Zintzaras, Emmanouil Saloustros

Published Feb 5, 2019 · Vol. 10, No. 11 · pp. 1209-1216

Safety and effectiveness of FOLFOXIRI plus molecular target drug therapy for metastatic colorectal cancer: A multicenter retrospective study Research Paper

Takatsugu Ogata, Hironaga Satake, Misato Ogata, Yukimasa Hatachi, Hayato Maruoka, Daisuke Yamashita, Hiroki Hashida, Madoka Hamada, Hisateru Yasui

Published Feb 1, 2019 · Vol. 10, No. 10 · pp. 1070-1084

The correlation of p22^phox and chemosensitivity in EGFR-TKI resistant lung adenocarcinoma Research Paper

Masayuki Kobayashi, Ryoko Saito, Yasuhiro Miki, Ren Nanamiya, Chihiro Inoue, Jiro Abe, Ikuro Sato, Yoshinori Okada, Hironobu Sasano

Published Feb 1, 2019 · Vol. 10, No. 10 · pp. 1119-1131

Oncofertility counselling in premenopausal women with HER2-positive breast cancer Research Perspective

Matteo Lambertini, Isabelle Demeestere, Giulia Viglietti, Evandro de Azambuja

Published Jan 29, 2019 · Vol. 10, No. 9 · pp. 926-929

Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer Research Paper

Chara Papadaki, Giannis Stoupis, Leuteris Tsalikis, Alexia Monastirioti, Maria Papadaki, Neofytos Maliotis, Michalis Stratigos, Georgios Mastrostamatis, Dimitrios Mavroudis, Sofia Agelaki

Published Jan 29, 2019 · Vol. 10, No. 9 · pp. 966-981

Triplet chemotherapy with docetaxel, cisplatin and S-1 for unresectable advanced squamous cell carcinoma of the esophagus: phase I/II trial results Research Paper

Toshiyasu Ojima, Masaki Nakamura, Mikihito Nakamori, Masahiro Katsuda, Keiji Hayata, Junya Kitadani, Shimpei Maruoka, Toshio Shimokawa, Hiroki Yamaue

Published Jan 25, 2019 · Vol. 10, No. 8 · pp. 847-855

Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer Research Paper

Manolo D'Arcangelo, Armida D'Incecco, Claudia Ligorio, Stefania Damiani, Maurizio Puccetti, Sara Bravaccini, Luigi Terracciano, Chiara Bennati, Gabriele Minuti, Silvia Vecchiarelli, Lorenza Landi, Marina Milesi, Alberto Meroni, Sara Ravaioli, Maria Maddalena Tumedei, Matteo Incarbone, Federico Cappuzzo

Published Jan 15, 2019 · Vol. 10, No. 5 · pp. 561-572

A single-center experience of post-transplant lymphomas involving the central nervous system with a review of current literature Research Paper

Anju John John Velvet, Shiv Bhutani, Stavros Papachristos, Reena Dwivedi, Michael Picton, Titus Augustine, Muir Morton

Published Jan 11, 2019 · Vol. 10, No. 4 · pp. 437-448

Fibroblast growth factor receptor 1 (FGFR1) as a therapeutic target in adenoid cystic carcinoma of the lacrimal gland Research Paper

Ravi Doddapaneni, Wensi Tao, Andrea Naranjo, Neda Nikpoor, David T. Tse, Daniel Pelaez

Published Jan 11, 2019 · Vol. 10, No. 4 · pp. 480-493

Concurrent chemotherapy in oropharyngeal cancer: Cisplatin wins Editorial

Arya Amini, Sana D. Karam

Published Jan 10, 2019 · Vol. 10, No. 6 · pp. 624-625

Immune checkpoint inhibitors in EGFR-mutation positive TKI-treated patients with advanced non-small-cell lung cancer network meta-analysis Meta-Analysis

Luigi Cavanna, Chiara Citterio, Elena Orlandi

Published Jan 4, 2019 · Vol. 10, No. 2 · pp. 209-215

DNA polymerases as chemotherapy targets: promise and challenges Editorial

Kristin A. Eckert, Ryan P. Barnes

Published Jan 3, 2019 · Vol. 10, No. 6 · pp. 620-621

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Characterization of cancer-associated IDH2 mutations that differ in tumorigenicity, chemosensitivity and 2-hydroxyglutarate production Research Paper

Evaluation of gilteritinib in combination with chemotherapy in preclinical models of FLT3-ITD⁺ acute myeloid leukemia Research Paper

The combined efficacy of OTS964 and temozolomide for reducing the size of power-law coded heterogeneous glioma stem cell populations Research Paper

AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple negative breast cancer Research Paper

ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation Priority Research Paper

Phospho-ERK levels as predictors for chemotherapy of rectal carcinoma Research Paper

Body surface area-based versus concentration-based intraperitoneal perioperative chemotherapy in a rat model of colorectal peritoneal surface malignancy: pharmacologic guidance towards standardization Research Paper

Myeloid cell leukemia-1 dependence in acute myeloid leukemia: a novel approach to patient therapy Review

Taxane & cyclophosphamide vs anthracycline & taxane-based chemotherapy as adjuvant treatment for breast cancer: a pooled analysis of randomized controlled trials by the Hellenic Academy of Oncology Research Paper

Safety and effectiveness of FOLFOXIRI plus molecular target drug therapy for metastatic colorectal cancer: A multicenter retrospective study Research Paper

The correlation of p22^phox and chemosensitivity in EGFR-TKI resistant lung adenocarcinoma Research Paper

Oncofertility counselling in premenopausal women with HER2-positive breast cancer Research Perspective

Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer Research Paper

Triplet chemotherapy with docetaxel, cisplatin and S-1 for unresectable advanced squamous cell carcinoma of the esophagus: phase I/II trial results Research Paper

Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer Research Paper

A single-center experience of post-transplant lymphomas involving the central nervous system with a review of current literature Research Paper

Fibroblast growth factor receptor 1 (FGFR1) as a therapeutic target in adenoid cystic carcinoma of the lacrimal gland Research Paper

Concurrent chemotherapy in oropharyngeal cancer: Cisplatin wins Editorial

Immune checkpoint inhibitors in EGFR-mutation positive TKI-treated patients with advanced non-small-cell lung cancer network meta-analysis Meta-Analysis

DNA polymerases as chemotherapy targets: promise and challenges Editorial

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Characterization of cancer-associated IDH2 mutations that differ in tumorigenicity, chemosensitivity and 2-hydroxyglutarate production Research Paper

Evaluation of gilteritinib in combination with chemotherapy in preclinical models of FLT3-ITD+ acute myeloid leukemia Research Paper

The combined efficacy of OTS964 and temozolomide for reducing the size of power-law coded heterogeneous glioma stem cell populations Research Paper

AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple negative breast cancer Research Paper

ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation Priority Research Paper

Phospho-ERK levels as predictors for chemotherapy of rectal carcinoma Research Paper

Body surface area-based versus concentration-based intraperitoneal perioperative chemotherapy in a rat model of colorectal peritoneal surface malignancy: pharmacologic guidance towards standardization Research Paper

Myeloid cell leukemia-1 dependence in acute myeloid leukemia: a novel approach to patient therapy Review

Taxane & cyclophosphamide vs anthracycline & taxane-based chemotherapy as adjuvant treatment for breast cancer: a pooled analysis of randomized controlled trials by the Hellenic Academy of Oncology Research Paper

Safety and effectiveness of FOLFOXIRI plus molecular target drug therapy for metastatic colorectal cancer: A multicenter retrospective study Research Paper

The correlation of p22phox and chemosensitivity in EGFR-TKI resistant lung adenocarcinoma Research Paper

Oncofertility counselling in premenopausal women with HER2-positive breast cancer Research Perspective

Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer Research Paper

Triplet chemotherapy with docetaxel, cisplatin and S-1 for unresectable advanced squamous cell carcinoma of the esophagus: phase I/II trial results Research Paper

Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer Research Paper

A single-center experience of post-transplant lymphomas involving the central nervous system with a review of current literature Research Paper

Fibroblast growth factor receptor 1 (FGFR1) as a therapeutic target in adenoid cystic carcinoma of the lacrimal gland Research Paper

Concurrent chemotherapy in oropharyngeal cancer: Cisplatin wins Editorial

Immune checkpoint inhibitors in EGFR-mutation positive TKI-treated patients with advanced non-small-cell lung cancer network meta-analysis Meta-Analysis

DNA polymerases as chemotherapy targets: promise and challenges Editorial

Evaluation of gilteritinib in combination with chemotherapy in preclinical models of FLT3-ITD⁺ acute myeloid leukemia Research Paper

The correlation of p22^phox and chemosensitivity in EGFR-TKI resistant lung adenocarcinoma Research Paper